https://www.selleckchem.com/pr....oducts/oxidopamine-h
In addition, the real dataset from QIN-BREAST-DCE-MRI was analyzed, and we observed an improved pharmacokinetic parameter estimation to distinguish the treatment response to chemotherapy applied to breast cancer. Our model improved the accuracy and stability of the tissue-specific estimation of the fractional volumes and kinetic parameters in DCE-MRI data, and improved the robustness to noise, providing more accurate kinetics for more precise prognosis and therapeutic response evaluation using DCE-MRI. Our model improve
Me gusta
Comentario
Compartir
